Anthera Pharmaceuticals, founded in the United States, is a biopharmaceutical company dedicated to developing innovative treatments for diseases associated with inflammation and autoimmune disorders. The company's core mission is to address unmet medical needs in these areas by advancing a pipeline of novel therapeutics. Anthera's product portfolio includes investigational drugs aimed at conditions such as lupus, cystic fibrosis, and other inflammatory diseases, targeting a market that requires more effective and specialized treatment options.

Notable figures associated with Anthera Pharmaceuticals include experienced professionals in the biotech and pharmaceutical industries, though specific names are not provided. The company has garnered attention from investors interested in the potential of its pipeline to address significant health challenges. Key achievements include progressing several drug candidates through various stages of clinical trials, demonstrating their commitment to rigorous scientific research. Anthera's impact lies in its potential to bring new, effective treatments to patients suffering from debilitating inflammatory and autoimmune conditions.